Fiji vs Saint Vincent and the Grenadines: Tuberculosis treatment success rate
Fiji
60.0%
in 2023
Saint Vincent and the Grenadines
60.0%
in 2022
Fiji rank
183rd
Saint Vincent and the Grenadines rank
183rd
Tuberculosis treatment success rate over time
- Fiji
- Saint Vincent and the Grenadines
How they compare
Fiji currently reports 60.0% against 60.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 7 times across 16 shared years of data; in 1997 it was Fiji ahead.
Fiji ranks 183rd and Saint Vincent and the Grenadines ranks 183rd of 206 countries.
Across the 4 decades both report, Fiji averaged higher in 3 and Saint Vincent and the Grenadines in 1.
Head to head by decade
| Decade | Fiji | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 91.5% | 87.0% | 4.5% | Fiji |
| 2000s | 78.6% | 65.6% | 13.0% | Fiji |
| 2010s | 70.2% | 51.3% | 18.8% | Fiji |
| 2020s | 53.3% | 55.3% | 2.0% | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Fiji or Saint Vincent and the Grenadines?
- Fiji, at 60.0% against 60.0% in Saint Vincent and the Grenadines as of 2023.
- What is the difference in tuberculosis treatment success rate between Fiji and Saint Vincent and the Grenadines?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Saint Vincent and the Grenadines?
- 16 years are reported by both, from 1997 to 2022.
- How do Fiji and Saint Vincent and the Grenadines rank globally for tuberculosis treatment success rate?
- Fiji ranks 183rd and Saint Vincent and the Grenadines ranks 183rd of 206 countries.
- Where does this data come from?
- WHO (2025) β with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.